San Francisco-based genetic diagnostics company Invitae has acquired Good Start Genetics and CombiMatrix to add prenatal and paediatric testing to its services. Good Start offers carrier screening and preimplantation genetic testing, while CombiMatrix provides preimplantation testing as well and also panels for analysing miscarriages and paediatric developmental disorders. Invitae is aiming to be a leader in supplying genetic information for in-vitro fertilisation and reproductive medicine. Invitae will pay $18.3m in cash and assume $27m in debt for Good Start, and will issue $6m in common stock to CombiMatrix shareholders. Invitae wants to expand its genetic services to all stages of life.
San Francisco-based genetic diagnostics company Invitae has acquired Good Start Genetics and CombiMatrix to add prenatal and paediatric testing to its services. Good Start offers carrier screening and preimplantation genetic testing, while CombiMatrix provides preimplantation testing as well and also panels for analysing miscarriages and paediatric developmental disorders. Invitae is aiming to be a leader in supplying genetic information for in-vitro fertilisation and reproductive medicine. Invitae will pay $18.3m in cash and assume $6m in debt for Good Start, and will issue $27m in common stock to CombiMatrix shareholders. Invitae wants to expand its genetic services to all stages of life.